Nasdaq:US$18.16 (-0.83) | HKEX:HK$30.90 (+0.55) | AIM:£2.90 (-0.14)
搜索
新闻档案

通过选择所需的新闻类型，可以获得最新的公告或演示文稿。

请使用 「新闻主题」进一步挑选公告类别。
 

所有公告的全文可以PDF文件的形式下载。为方便起见，某些公告的部分或全部文字内容以网页的方式呈现。如存有任何不一致之处，请以PDF版本为准。

新闻类型
公告及新闻稿
演示文稿
新闻主题
其他业务
监管通知
肿瘤学 / 免疫学
集团
12
3
45678
找到相关结果： 352
公告及新闻稿, 监管通知 | 2021-07-07

月报表
公告及新闻稿, 监管通知 | 2021-07-02

TR-1: Standard form for notification of major holdings
NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii:
阅读更多
伦敦证交所公告 (PDF)香港交易所 – 海外监管公告 (PDF)
公告及新闻稿, 监管通知 | 2021-06-30

Total Voting Rights
Hong Kong, Shanghai, & Florham Park, NJ: Wednesday, June 30, 2021: HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM: HCM, HKEX: 13) hereby notifies the market that as at June 30, 2021, the issued share capital of HUTCHMED consisted of 848,51
阅读更多
香港交易所 – 海外监管公告 (PDF)伦敦证交所公告 (PDF)
公告及新闻稿, 监管通知 | 2021-06-30

Holdings in Company
Hong Kong, Shanghai, & Florham Park, NJ: Wednesday, June 30, 2021:  HUTCHMED (China) Limited (“HUTCHMED” or the “Company”) (Nasdaq/AIM: HCM, HKEX: 13) announces that, in connection with its global offering (the "Global Offering") of 104,
阅读更多
香港交易所 – 海外监管公告 (PDF)伦敦证交所公告 (PDF)
公告及新闻稿, 监管通知 | 2021-06-29

Blocklisting Six Monthly Return
Hong Kong, Shanghai, & Florham Park, NJ — Tuesday, June 29, 2021: HUTCHMED (China) Limited (“HUTCHMED” or the “Company”) (Nasdaq/AIM: HCM) announces the following blocklisting six monthly return:   1. Name of applicant:
阅读更多
查看通告 (PDF)
公告及新闻稿, 监管通知 | 2021-06-29

董事名單及其角色與職能
公告及新闻稿, 监管通知 | 2021-06-29

發售價及配發結果公告
香港交易所公告 (PDF)
公告及新闻稿, 监管通知 | 2021-06-18

Disclosure Update
Hong Kong, Shanghai, & Florham Park, NJ — Friday, June 18, 2021: HUTCHMED (China) Limited (“HUTCHMED” or the “Company”) (Nasdaq/AIM: HCM) today filed the Post Hearing Information Pack (the “PHIP”) with the Stock Exchange of Hong Kon
阅读更多
公告及新闻稿, 监管通知 | 2021-04-28

股东周年大会结果（只备英文版本）
Hong Kong, Shanghai, & Florham Park, NJ: Wednesday, April 28, 2021: Hutchison China MediTech Limited (“HUTCHMED” or the “Company”) (Nasdaq/AIM: HCM) today announces that all ordinary resolutions and special resolutions put to its Annual G
阅读更多
查看通告 (PDF)（只备英文版本）
公告及新闻稿, 监管通知 | 2021-04-23

Vesting of awards under the Long Term Incentive Plan
Hong Kong, Shanghai & Florham Park, NJ: Friday, April 23, 2021: Hutchison China MediTech Limited (“HUTCHMED”) (Nasdaq/AIM: HCM) announces that the non-performance based awards granted under the Long Term Incentive Plan (“LTIP”) on April 2
阅读更多
查看通告 (PDF)
公告及新闻稿, 监管通知 | 2021-04-14

Notification of Dilution of Voting Rights
Hong Kong, Shanghai, & Florham Park, NJ: Wednesday, April 14, 2021:  Hutchison China MediTech Limited (“HUTCHMED”) (Nasdaq/AIM: HCM) was notified that CK Hutchison Holdings Limited (“CK Hutchison”) shareholding[1] in HUTCHMED remains unc
阅读更多
查看通告 (PDF)
公告及新闻稿, 监管通知 | 2021-03-29

Grant of Awards under Long Term Incentive Plan and Share Options under Share Option Scheme
Hong Kong, Shanghai, & Florham Park, NJ: Monday, March 29, 2021: Hutchison China MediTech Limited (“HUTCHMED”) (Nasdaq/AIM: HCM) announces that on March 26, 2021, it granted conditional awards (“LTIP Awards”) under the Long Term Incentive
阅读更多
查看通告 (PDF)
公告及新闻稿, 监管通知 | 2021-03-10

Vesting of awards under the Long Term Incentive Plan
Hong Kong, Shanghai, & Florham Park, NJ: Wednesday, March 10, 2021: Hutchison China MediTech Limited (“HUTCHMED”) (Nasdaq/AIM: HCM) announces that following the announcement of the 2020 annual results of HUTCHMED on March 4, 2021, 2,656 Ameri
阅读更多
查看通告 (PDF)
公告及新闻稿, 监管通知 | 2020-12-31

Blocklisting Six Monthly Return
London: Thursday, December 31, 2020: Hutchison China MediTech Limited (“Chi-Med” or the “Company”) (AIM/Nasdaq: HCM) announces the following blocklisting six monthly return:   1. Name of applicant: Hutchison China MediTech
阅读更多
查看通告 (PDF)
公告及新闻稿, 监管通知 | 2020-12-31

Total Voting Rights
London: Thursday, December 31, 2020: Hutchison China MediTech Limited (“Chi-Med”) (AIM/Nasdaq: HCM) hereby notifies the market that as at December 31, 2020, the issued share capital of Chi-Med consisted of 727,722,215 ordinary shares of US$0.10 e
阅读更多
查看通告 (PDF)
公告及新闻稿, 监管通知 | 2020-12-15

Grant of Share Options under Share Option Scheme
London: Tuesday, December 15, 2020: Hutchison China MediTech Limited (“Chi-Med”) (Nasdaq/AIM: HCM) announces that on December 14, 2020, it granted share options under the Share Option Scheme conditionally adopted by Chi-Med at its Annual General
阅读更多
查看通告 (PDF)
公告及新闻稿, 监管通知 | 2020-11-30

Total Voting Rights
London: Monday, November 30, 2020: Hutchison China MediTech Limited (“Chi-Med”) (AIM/Nasdaq: HCM) hereby notifies the market that as at November 30, 2020, the issued share capital of Chi-Med consisted of 727,702,215 ordinary shares of US$0.10 eac
阅读更多
查看通告 (PDF)
公告及新闻稿, 监管通知 | 2020-11-27

Notification of Dilution of Voting Rights
London: Friday, November 27, 2020:  Hutchison China MediTech Limited (“Chi-Med”) (Nasdaq/AIM: HCM) was notified that CK Hutchison Holdings Limited (“CK Hutchison”) shareholding[1] in Chi-Med remains unchanged, at 332,478,770 ordinary shares
阅读更多
查看通告 (PDF)
公告及新闻稿, 监管通知, 肿瘤学 / 免疫学 | 2020-11-05

和黄医药于第62届美国血液学会（ASH）年会公布HMPL-689临床数据
中国香港、上海和美国新泽西州：2020年11月5日，星期四 ：和黄中国医药科技有限公司（简称“和黄医药”或“Chi-Med”）（纳斯达克/伦敦证交所：HCM）今日宣布，将于2020年12月5至8日召开的
阅读更多
下载新闻稿 (PDF)
公告及新闻稿, 监管通知 | 2020-10-30

Total Voting Rights
London: Friday, October 30, 2020: Hutchison China MediTech Limited (“Chi-Med”) (AIM/Nasdaq: HCM) hereby notifies the market that as at October 30, 2020, the issued share capital of Chi-Med consisted of 711,025,545 ordinary shares of US$0.10 each,
阅读更多
下载通告 (PDF)
公告及新闻稿, 监管通知 | 2020-09-30

Total Voting Rights
London: Wednesday, September 30, 2020: Hutchison China MediTech Limited (“Chi-Med”) (AIM/Nasdaq: HCM) hereby notifies the market that as at September 30, 2020, the issued share capital of Chi-Med consisted of 710,785,545 ordinary shares of US$0.1
阅读更多
查看通告 (PDF)
公告及新闻稿, 监管通知 | 2020-08-28

Total Voting Rights
London: Friday, August 28, 2020: Hutchison China MediTech Limited (“Chi-Med”) (AIM/Nasdaq: HCM) hereby notifies the market that as at August 28, 2020, the issued share capital of Chi-Med consisted of 710,594,765 ordinary shares of US$0.10 each, w
阅读更多
下载通告 (PDF)
公告及新闻稿, 监管通知 | 2020-08-12

Grant of Share Options under Share Option Scheme
Hong Kong, Shanghai, & Florham Park, NJ: Wednesday, August 12, 2020: Hutchison China MediTech Limited (“Chi-Med”) (Nasdaq/AIM: HCM) announces that on August 11, 2020, it granted share options under the Share Option Scheme conditionally adopte
阅读更多
查看通告 (PDF)
公告及新闻稿, 监管通知 | 2020-07-08

TR-1: Standard form for notification of major holdings
NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: Hutch
阅读更多
查看通告 (PDF)
公告及新闻稿, 监管通知 | 2020-07-07

TR-1: Standard form for notification of major holdings
NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: Hutch
阅读更多
查看通告 (PDF)
公告及新闻稿, 监管通知 | 2020-07-07

Notification of Dilution of Voting Rights
London: Tuesday, July 7, 2020: Hutchison China MediTech Limited (“Chi-Med”) (Nasdaq/AIM: HCM) was notified that CK Hutchison Holdings Limited (“CK Hutchison”) shareholding1 in Chi-Med remains unchanged, at 332,478,770 ordinary shares of par v
阅读更多
查看通告 (PDF)
公告及新闻稿, 监管通知 | 2020-06-29

Blocklisting Six Monthly Return
London: Monday, June 29, 2020: Hutchison China MediTech Limited (“Chi-Med” or the “Company”) (AIM/Nasdaq: HCM) announces the following blocklisting six monthly return:   1. Name of applicant: Hutchison China MediTech Limite
阅读更多
查看通告 (PDF)
公告及新闻稿, 监管通知 | 2020-04-29

Grant of Share Options under Share Option Scheme
London: Wednesday, April 29, 2020: Hutchison China MediTech Limited (“Chi-Med”) (Nasdaq/AIM: HCM) announces that on April 28, 2020, in accordance with its new incentive policy outlined in its full year results announcement on March 3, 2020, it gr
阅读更多
查看通告 (PDF)
公告及新闻稿, 监管通知 | 2020-04-27

股东周年大会结果（只备英文版本）
London: Monday, April 27, 2020: Hutchison China MediTech Limited (“Chi-Med”) (Nasdaq/AIM: HCM) today announces that all ordinary resolutions and special resolutions put to its Annual General Meeting (“AGM”) held on April 27, 2020 were duly pa
阅读更多
查看通告 (PDF) （只备英文版本）
公告及新闻稿, 监管通知 | 2020-04-21

Grant of Awards under Long Term Incentive Plan and Share Options under Share Option Scheme
London: Tuesday, April  21, 2020: Hutchison China MediTech Limited (“Chi-Med”) (Nasdaq/AIM: HCM) announces that on April  20, 2020, in accordance with the new incentive policy outlined in its full year results announcement on March 3, 2020, it
阅读更多
View Announcement (PDF)
公告及新闻稿, 监管通知 | 2020-03-09

Vesting of awards under the Long Term Incentive Plan
London: Monday, March 9, 2020: Hutchison China MediTech Limited (“Chi-Med”) (Nasdaq/AIM: HCM) announces that following the announcement of the 2019 annual results of Chi-Med on March 3, 2020, the following awards granted under the Long Term Incen
阅读更多
View Announcement (PDF)
公告及新闻稿, 监管通知 | 2020-01-29

TR-1: Standard form for notification of major holdings
NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: Hutch
阅读更多
下载通告 (PDF)
公告及新闻稿, 监管通知 | 2019-12-31

Total Voting Rights
London: Tuesday, December 31, 2019: Hutchison China MediTech Limited (“Chi-Med”) (AIM/Nasdaq: HCM) hereby notifies the market that as at December 31, 2019, the issued share capital of Chi-Med consisted of 666,906,450 ordinary shares of US$0.10 ea
阅读更多
下載通告 (PDF)
公告及新闻稿, 监管通知 | 2019-12-31

Blocklisting Six Monthly Return
London: Tuesday, December 31, 2019: Hutchison China MediTech Limited (“Chi-Med” or the “Company”) (AIM/Nasdaq: HCM) announces the following blocklisting six monthly return: 1. Name of applicant: Hutchison China MediTech Limited
阅读更多
下载通告 (PDF)
公告及新闻稿, 监管通知 | 2019-12-12

Grant of Share Options under Share Option Scheme
London: Thursday, December 12, 2019: Hutchison China MediTech Limited (“Chi-Med”) (AIM/Nasdaq: HCM) announces that on December 11, 2019, it granted share options under the Share Option Scheme conditionally adopted by Chi-Med at its Annual General
阅读更多
下载通告 (PDF)
公告及新闻稿, 监管通知 | 2019-11-29

Total Voting Rights
London: Friday, November 29, 2019: Hutchison China MediTech Limited (“Chi-Med”) (AIM/Nasdaq: HCM) hereby notifies the market that as at November 29, 2019, the issued share capital of Chi-Med consisted of 666,886,450 ordinary shares of US$0.10 eac
阅读更多
下载通告 (PDF)
公告及新闻稿, 监管通知 | 2019-10-10

Grant of Share Options under Share Option Scheme
London: Thursday, October 10, 2019: Hutchison China MediTech Limited (“Chi-Med”) (AIM/Nasdaq: HCM) announces that on October 9, 2019, it granted share options under the Share Option Scheme conditionally adopted by Chi-Med at its Annual General Me
阅读更多
公告及新闻稿, 监管通知 | 2019-10-03

TR-1: Form for notification of major holdings
NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: Hutch
阅读更多
公告及新闻稿, 监管通知 | 2019-09-30

Total Voting Rights
London: Monday, September 30, 2019: Hutchison China MediTech Limited (“Chi-Med”) (AIM/Nasdaq: HCM) hereby notifies the market that as at September 30, 2019, the issued share capital of Chi-Med consisted of 666,786,450 ordinary shares of US$0.10 e
阅读更多
公告及新闻稿, 监管通知 | 2019-08-30

Total Voting Rights
London: Friday, August 30, 2019: Hutchison China MediTech Limited (“Chi-Med”) (AIM/Nasdaq: HCM) hereby notifies the market that as at August 30, 2019, the issued share capital of Chi-Med consisted of 666,777,450 ordinary shares of US$0.10 each, w
阅读更多
公告及新闻稿, 监管通知 | 2019-08-20

TR-1: Form for notification of major holdings
NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: Hut
阅读更多
公告及新闻稿, 监管通知 | 2019-07-30

TR-1: Form for notification of major holdings
NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: Hut
阅读更多
公告及新闻稿, 监管通知 | 2019-07-03

TR-1: Form for notification of major holdings
NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: Hutch
阅读更多
公告及新闻稿, 监管通知 | 2019-07-03

TR-1: Form for notification of major holdings
NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: Hut
阅读更多
公告及新闻稿, 监管通知 | 2019-06-28

Blocklisting Six Monthly Return
London: Friday, June 28, 2019: Hutchison China MediTech Limited (“Chi-Med” or the “Company”) (AIM/Nasdaq: HCM) announces the following blocklisting six monthly return:   1. Name of applicant: Hutchison China MediTech Limite
阅读更多
公告及新闻稿, 监管通知 | 2019-06-12

Block Admission Applications and Total Voting Rights
London: Wednesday, June 12, 2019: Hutchison China MediTech Limited (“Chi-Med”) (AIM/Nasdaq: HCM) today announces that the following applications have been made to the London Stock Exchange plc for the block admission of ordinary shares, par value
阅读更多
公告及新闻稿, 监管通知 | 2019-06-06

Disclosure Update
London: Thursday, June 6, 2019: Hutchison China MediTech Limited (“Chi-Med” or the “Company”) (AIM/Nasdaq: HCM) today filed the Post Hearing Information Pack (the “PHIP”) with the Stock Exchange of Hong Kong Limited (“SEHK”) in connec
阅读更多
公告及新闻稿, 监管通知 | 2019-05-22

Grant of Share Options under Share Option Scheme
London: Wednesday, May 22, 2019: Hutchison China MediTech Limited (“Chi-Med”) (AIM/Nasdaq: HCM) announces that on May 21, 2019, it granted share options under the Share Option Scheme conditionally adopted by Chi-Med at its Annual General Meeting
阅读更多
View Announcement (PDF)
公告及新闻稿, 监管通知 | 2019-04-24

股东周年大会结果（只备英文版本）
London: Wednesday, April 24, 2019: Hutchison China MediTech Limited (“Chi-Med”) (AIM/Nasdaq: HCM) today announces that all ordinary resolutions and special resolutions put to its Annual General Meeting (“AGM”) held on April 24, 2019 were duly
阅读更多
Download Announcement (PDF)
公告及新闻稿, 监管通知 | 2019-04-15

Disclosure Update
London: Monday, April 15, 2019: Hutchison China MediTech Limited (“Chi-Med” or the “Company”) (AIM/Nasdaq: HCM) today filed an application (the “Listing Application”) with the Stock Exchange of Hong Kong Limited (“SEHK”) in connection
阅读更多
Download Announcement (PDF)
12
3
45678